- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
An Improved Synthesis of the New Angiotensin Converting Enzyme Inhibitor CV-5975 via a Chemoenzymatic Process(Organic,Chemical)
-
- KORI MASAKUNI
- Central Research Division, Takeda Chemical Industries, Ltd.
-
- ITOH KATSUMI
- Central Research Division, Takeda Chemical Industries, Ltd.
-
- SUGIHARA HIROSADA
- Central Research Division, Takeda Chemical Industries, Ltd.
Search this article
Description
A chemoenzymatic synthesis of the new angiotensin converting enzyme inhibitor CV-5975 (1) is described. The optically active key intermediate for the synthesis of 1, ethyl (R-6-(1-benzyloxycarbonyl-4-piperidyl)-2-hydroxyhexanoate ((R)-4), was prepared by kinetic resolution of the racemic α-hydroxyester ((RS)-4) with a lipase and also by asymmetric reduction of the α-oxoester (3) with baker's yeast, The enantiomeric excess (ee) of the a-hydroxyester ((R)-4) produced by these enzymatic procedures exceeded 60%. This optically active alcohol ((R)-4) was converted to its mesylate ((R)-5), which was then subjected to S_N2 reaction with the aminobenzothiazepine derivative (2) followed by deprotection to yield 1.
Journal
-
- Chemical & pharmaceutical bulletin
-
Chemical & pharmaceutical bulletin 35 (6), 2319-2326, 1987-06-25
The Pharmaceutical Society of Japan
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1573668927092471808
-
- NII Article ID
- 110006281219
-
- NII Book ID
- AA00602100
-
- ISSN
- 00092363
-
- Text Lang
- en
-
- Data Source
-
- CiNii Articles